id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-D-0349-0011,FDA,FDA-2013-D-0349,Providing Postmarketing Periodic Safety Reports in the ICH E2C(R2) Format (Periodic Benefit-Risk Evaluation Report) Guidance for Industry,Other,Guidance,2016-11-29T05:00:00Z,2016,11,2016-11-29T05:00:00Z,,2024-12-20T19:47:11Z,,1,0,09000064823c72be
FDA-2013-D-0349-0010,FDA,FDA-2013-D-0349,"Providing Postmarketing Periodic Safety Reports in the International
Council for Harmonisation E2C(R2) Format (Periodic Benefit-Risk
Evaluation Report); Guidance for Industry; Availability",Notice,Notice of Availability,2016-11-29T05:00:00Z,2016,11,2016-11-29T05:00:00Z,,2016-11-29T15:53:39Z,2016-28606,0,0,09000064823c5f73